TrialBlood cancer journal2019

ABCB1 SNP predicts outcome in patients with acute myeloid leukemia treated with Gemtuzumab ozogamicin: a report from Children's Oncology Group AAML0531 Trial.

Roya Rafiee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.